We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » US FDA Calls for Labeling Update for Elastomeric Infusion Devices
US FDA Calls for Labeling Update for Elastomeric Infusion Devices
December 14, 2009
Manufacturers of pumps to infuse local anesthetics must update their product labels to warn about a potential serious adverse effect when the pumps are
used for continuous intra-articular infusions, the U.S. Food and Drug Administration (FDA) says.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor